Evidence map›Paper›PMID 29380563›Full record

Trial reportStem cells translational medicine2018

CD34

Sabina Frljak, Martina Jaklic, Gregor Zemljic, Andraz Cerar, Gregor Poglajen, Bojan Vrtovec

Open access · goldAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Stem cells translational medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 5 pooled it
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 5 syntheses or guidelines pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Stem cell therapy for dilated cardiomyopathy.The Cochrane database of systematic reviews · 2021
    Pooled it
  5. Pooled it
  6. Trial
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Effects of intravitreal injection of human CD34Experimental eye research · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Sabina FrljakAdvanced Heart Failure and Transplantation Centre, UMC Ljubljana, Slovenia.
Martina JaklicAdvanced Heart Failure and Transplantation Centre, UMC Ljubljana, Slovenia.
Gregor ZemljicAdvanced Heart Failure and Transplantation Centre, UMC Ljubljana, Slovenia.
Andraz CerarAdvanced Heart Failure and Transplantation Centre, UMC Ljubljana, Slovenia.
Gregor PoglajenAdvanced Heart Failure and Transplantation Centre, UMC Ljubljana, Slovenia.
Bojan VrtovecAdvanced Heart Failure and Transplantation Centre, UMC Ljubljana, Slovenia.ORCID 0000-0002-7383-1281
Art Research Centre of the Slovak Academy of Sciences · SKStanford University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We investigated the effects of CD34

Indexed as

Antigens, CD34Cardiomyopathy, DilatedCell- and Tissue-Based TherapyCell TransplantationEchocardiographyFemaleGranulocyte Colony-Stimulating FactorHeart FailureHeart SeptumHeart VentriclesHumansMaleMiddle AgedMyocardiumNatriuretic Peptide, BrainProspective StudiesAntigens, CD34Granulocyte Colony-Stimulating FactorNatriuretic Peptide, BrainCD34+ cellsDilated cardiomyopathyHeart failureRight ventricular function

Identifiers

PMID29380563
PMCPMC5788875
OpenAlexW2791446385

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.